ARTICLE | Clinical News
Donepezil regulatory update
December 6, 2010 8:00 AM UTC
Ranbaxy said FDA approved generic versions of 5 and 10 mg donepezil to treat Alzheimer's disease in the U.S. Eisai Co. Ltd. (Tokyo:4523; Osaka:4523, Tokyo, Japan) and Pfizer Inc. (NYSE:PFE, New York...